- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03384368
A Modified Placement of Two Additional Pedicle Screws at the Fracture Level for the Treatment of Thoracolumbar Burst Fractures--a Study Protocol of a Randomised Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China, 325000
- Recruiting
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
-
Contact:
- WENFEI NI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- 18 years of age or above.
- single thoracolumbar burst fractures
- AO type A3 or A4 fractures
- Thoracolumbar Injury Classification and Severity Score (TLICS) of more than 4 and duration of < 2 weeks
- application of posterior short-segment pedicle screws instrumentation at the fracture level Exclusion criteria
1. previous pedicle instrumentation at the same level 2. multi-segmental thoracolumbar fractures or not AO type A3 or A4 are found 3. pregnancy 4. active infection or surgical site of the previous infection 5. planned emigration abroad within 2 years after inclusion 6. suffering from illness or long-term use of certain drugs affecting the stability of the spinal environment, such as metabolic bone disease, spinal tuberculosis and so on 7. the current use of anticoagulant (such as warfarin) or postoperative heparin for more than 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Screw-Distraction (SD) group
six pedicle screws were implanted firstly, then distraction was achieved.
|
four pedicle screws were implanted into the upper vertebra and the lower vertebral body of the fractured vertebra.
Then, immediate reduction and decompression were achieved by applying distraction of rod.
Finally, two additional screws were introduced at fracture level
|
|
Experimental: Distraction-Screw (DS) group
four pedicle screws were implanted firstly, then distraction was achieved, two additional screws were introduced at the fracture level at last.
|
four pedicle screws were implanted into the upper vertebra and the lower vertebral body of the fractured vertebra.
Then, immediate reduction and decompression were achieved by applying distraction of rod.
Finally, two additional screws were introduced at fracture level
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
compression ratio change of anterior border of vertebral body height
Time Frame: preoperatively, intraoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
using X-ray fluorescence
|
preoperatively, intraoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
|
Depth of nail into injured vertebrae
Time Frame: at postoperation immediately
|
using X-ray fluorescence
|
at postoperation immediately
|
|
Kyphosis (Cobb) angle change
Time Frame: preoperatively, intraoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
using X-ray fluorescence
|
preoperatively, intraoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: right after surgery
|
Unit of Measure is hour
|
right after surgery
|
|
intraoperative blood loss
Time Frame: right after surgery
|
Unit of Measure is ml
|
right after surgery
|
|
Complications
Time Frame: at postoperation immediately, 1, 3 and 6 months, and at 1 and 2 years postoperatively.
|
Pedicle fractures, intraoperative pars fractures, postoperative infection, deep venous thrombosis, nerve injury, and any other direct or indirect surgical complications will be recorded.
|
at postoperation immediately, 1, 3 and 6 months, and at 1 and 2 years postoperatively.
|
|
pain degree of back and lower limb
Time Frame: preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively.
|
The pain degree of back and lower limb during follow-up will be assessed by the VAS of back pain and VAS of leg pain
|
preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively.
|
|
Oswestry Disability Index (ODI) change
Time Frame: preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
The Oswestry Disability Index (ODI) will be asssessed by questionnaire
|
preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
|
The Japanese Orthopaedic Association (JOA) scores
Time Frame: preoperatively and postoperatively including day 3 and then 1, 3, 6, 12 and 24 months
|
Functional improvement is expressed by the rate of recovery of the JOA scores
|
preoperatively and postoperatively including day 3 and then 1, 3, 6, 12 and 24 months
|
|
The American Spinal Injury Association (ASIA) impairment scale
Time Frame: preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
Spinal Injury was assessed using ASIA
|
preoperatively, on day 3 postoperatively and then at 1, 3, 6, 12 and 24 months postoperatively
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAHoWMU-CR2017-08-115
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posterior Short-segment Pedicle Instrumentation
-
Centre Hospitalier Universitaire DijonCompletedIndication for Surgery of the Posterior Segment Under Locoregional AnaesthesiaFrance
-
Sohag UniversityNot yet recruitingEvaluation of Short Scar Periareolar Inferior Pedicle Reduction Mammoplasty in Oncoplastic Breast SurgeryEgypt
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingPatients Undergoing DMEK With a History of Anterior or Posterior Segment SurgeryFrance
-
Regeneron PharmaceuticalsActive, not recruitingActive Noninfectious Uveitis Affecting the Posterior SegmentUnited States
-
Case Comprehensive Cancer CenterCompletedShort Segment Barrett's Esophagus | Long Segment Barrett's EsophagusUnited States
-
Glenn JaffeCompletedUveitis Affecting the Posterior SegmentUnited States
-
Santen Inc.CompletedNon-Infectious Uveitis of the Posterior Segment of the EyeUnited States, France, Turkey, Italy, Austria, India
-
Alimera SciencesRecruitingNon-infectious Uveitis Affecting the Posterior Segment of the EyeSpain, Germany, United Kingdom
-
Edwards LifesciencesICON plcTerminatedSevere Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet ProlapseGermany, Spain, Switzerland
-
Alcon ResearchWithdrawnProliferative Diabetic Retinopathy | Vitreous Hemorrhage | Rhegmatogenous Retinal Detachment | Epiretinal Membrane | Vitreomacular Traction | Macular Hole | Visually Significant Vitreous Floater | Retained Lens Material in the Posterior SegmentUnited States